Patents by Inventor Martin Block

Martin Block has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20220040414
    Abstract: Diabetes management systems include an insulin delivery device and a monitoring device for detecting at least one characteristic relating to the insulin delivery device. Monitoring devices may comprise pen caps.
    Type: Application
    Filed: October 26, 2021
    Publication date: February 10, 2022
    Inventors: John Sjolund, Ambika Srinath, Andrew Bochenko, George Crothall, Bryan Mazlish, Lane Desborough, Jennifer Martin Block, Sarah Matarese, Linda Mackowiak
  • Publication number: 20210386936
    Abstract: One or more embodiments of the disclosure relate, generally, to a system to assist with manual dosing of insulin. Such a system may include a glucose sensor system, a reusable insulin dosing detector, and a recommendation system. The reusable insulin dosing detector may be configured to be reversibly connectable to a disposable component that may form part of an insulin manual delivery assembly. The reusable insulin dosing detector may be configured to detect insulin delivery associated with the insulin manual delivery assembly. The recommendation system may be configured to analyze blood glucose data and determine adjustments to insulin therapy settings.
    Type: Application
    Filed: July 29, 2021
    Publication date: December 16, 2021
    Inventors: John Sjolund, Ambika Srinath, Andrew Bochenko, George Crothall, Bryan Mazlish, Jennifer Martin Block, Sarah Matarese, Linda Mackowiak, Lane Desborough
  • Patent number: 11197964
    Abstract: One or more embodiments of the disclosure relate, generally, to a replacement pen cap for a medication injection pen comprising at least one temperature sensor for monitoring a temperature of a medication, detect dosing events, and determine that medication may be denatured based on temperature data, received analyte measurement data prior, and the detected dosing events.
    Type: Grant
    Filed: December 12, 2018
    Date of Patent: December 14, 2021
    Assignee: Bigfoot Biomedical, Inc.
    Inventors: John Sjolund, Ambika Srinath, Andrew Bochenko, George Crothall, Bryan Mazlish, Jennifer Martin Block, Sarah Matarese, Linda Mackowiak, Lane Desborough
  • Publication number: 20210369970
    Abstract: One or more embodiments of the disclosure are related, generally, to a reusable accessory for a manual medication delivery device. Such a reusable accessory may include a wireless communication interface, a detection circuitry, and a recommendation system. In one or more embodiments, an adapter may be configured to reversibly couple such a reusable accessory to a manual medication delivery device. Dosing events may be detected that are associated with dosing at the manual medication delivery device. Dose recommendations may be provided responsive to analyte measurements and/or dosing events.
    Type: Application
    Filed: August 16, 2021
    Publication date: December 2, 2021
    Inventors: John Sjolund, Ambika Srinath, Andrew Bochenko, George Crothall, Bryan Mazlish, Jennifer Martin Block, Sarah Matarese, Linda MacKowiak, Lane Desborough
  • Publication number: 20210353858
    Abstract: One or more embodiments of the disclosure relate, generally, to a diabetes management system. The diabetes management system may include a computing device that is configured to receive data relating to prior insulin use of a user and calculate a sliding scale glucose correction based, at least in part, on the data relating to prior insulin use.
    Type: Application
    Filed: July 29, 2021
    Publication date: November 18, 2021
    Inventors: John Sjolund, Ambika Srinath, Andrew Bochenko, George Crothall, Bryan Mazlish, Jennifer Martin Block, Sarah Matarese, Linda Mackowiak, Lane Desborough
  • Publication number: 20210346595
    Abstract: One or more embodiments relate, generally, to a reusable accessory for a medication injection pen. Such a reusable accessory may be adapted to be reversibly attached to a medication injection pen, and configured to detect an event associated with an injection of medication from the medication injection pen. It may also be configured to determine a percentage of medication that remains active for injection by the medication injection pen based on timing information and dosing event information.
    Type: Application
    Filed: July 21, 2021
    Publication date: November 11, 2021
    Inventors: John Sjolund, Ambika Srinath, Andrew Bochenko, George Crothall, Bryan Mazlish, Jennifer Martin Block, Sarah Matarese, Linda Mackowiak, Lane Desborough
  • Patent number: 11154660
    Abstract: Diabetes management systems include an insulin delivery device and a monitoring device for detecting at least one characteristic relating to the insulin delivery device. Monitoring devices may comprise pen caps.
    Type: Grant
    Filed: December 12, 2018
    Date of Patent: October 26, 2021
    Assignee: Bigfoot Biomedical, Inc.
    Inventors: John Sjolund, Ambika Srinath, Andrew Bochenko, George Crothall, Bryan Mazlish, Lane Desborough, Jennifer Martin Block, Sarah Matarese, Linda Mackowiak
  • Publication number: 20210290853
    Abstract: A monitoring feature, such as, for example, a pen cap, for an insulin delivery device may include at least one circuit adapted to detect at least one of a capping or decapping of the pen cap from an insulin pen and a processor for using information to the at least one of a capping or decapping of the pen cap. A monitoring feature for an insulin delivery device includes at least one circuit adapted to detect use of the insulin delivery device.
    Type: Application
    Filed: June 7, 2021
    Publication date: September 23, 2021
    Inventors: John Sjolund, Ambika Srinath, Andrew Bochenko, George Crothall, Bryan Mazlish, Lane Desborough, Jennifer Martin Block, Sarah Matarese, Linda Mackowiak
  • Patent number: 11116899
    Abstract: One or more embodiments of the disclosure relate, generally, to a diabetes management system. The diabetes management system may include a computing device that is configured to receive data relating to prior insulin use of a user and calculate a sliding scale glucose correction based, at least in part, on the data relating to prior insulin use.
    Type: Grant
    Filed: December 12, 2018
    Date of Patent: September 14, 2021
    Assignee: Bigfoot Biomedical, Inc.
    Inventors: John Sjolund, Ambika Srinath, Andrew Bochenko, George Crothall, Bryan Mazlish, Jennifer Martin Block, Sarah Matarese, Linda Mackowiak, Lane Desborough
  • Patent number: 11090439
    Abstract: One or more embodiments of the disclosure are related, generally, to a reusable accessory for a manual medication delivery device. Such a reusable accessory may include a wireless communication interface, a detection circuitry, and a recommendation system. In one or more embodiments, an adapter may be configured to reversibly couple such a reusable accessory to a manual medication delivery device. Dosing events may be detected that are associated with dosing at the manual medication delivery device. Dose recommendations may be provided responsive to analyte measurements and/or dosing events.
    Type: Grant
    Filed: December 12, 2018
    Date of Patent: August 17, 2021
    Assignee: Bigfoot Biomedical, Inc.
    Inventors: John Sjolund, Ambika Srinath, Andrew Bochenko, George Crothall, Bryan Mazlish, Jennifer Martin Block, Sarah Matarese, Linda Mackowiak, Lane Desborough
  • Patent number: 11083852
    Abstract: One or more embodiments of the disclosure relate, generally, to a system to assist with manual dosing of insulin. Such a system may include a glucose sensor system, a reusable insulin dosing detector, and a recommendation system. The reusable insulin dosing detector may be configured to be reversibly connectable to a disposable component that may form part of an insulin manual delivery assembly. The reusable insulin dosing detector may be configured to detect insulin delivery associated with the insulin manual delivery assembly. The recommendation system may be configured to analyze blood glucose data and determine adjustments to insulin therapy settings.
    Type: Grant
    Filed: December 12, 2018
    Date of Patent: August 10, 2021
    Assignee: Bigfoot Biomedical, Inc.
    Inventors: John Sjolund, Ambika Srinath, Andrew Bochenko, George Crothall, Bryan Mazlish, Jennifer Martin Block, Sarah Matarese, Linda Mackowiak, Lane Desborough
  • Patent number: 11077243
    Abstract: One or more embodiments relate, generally, to a reusable accessory for a medication injection pen. Such a reusable accessory may be adapted to be reversibly attached to a medication injection pen, and configured to detect an event associated with an injection of medication from the medication injection pen. It may also be configured to determine a percentage of medication that remains active for injection by the medication injection pen based on timing information and dosing event information.
    Type: Grant
    Filed: December 12, 2018
    Date of Patent: August 3, 2021
    Assignee: Bigfoot Biomedical, Inc.
    Inventors: John Sjolund, Ambika Srinath, Andrew Bochenko, George Crothall, Bryan Mazlish, Jennifer Martin Block, Sarah Matarese, Linda Mackowiak, Lane Desborough
  • Publication number: 20210205529
    Abstract: One or more embodiments of the disclosure relate, generally, to a pen cap for a manual insulin delivery device. Such a pen cap may include a wireless communication interface, a detection circuit, a user interface, and a processor and memory. The detection circuit may be configured to detect cappings and decappings of the pen cap from a manual insulin delivery device. Timing information and recommendations related to capping and decapping of the pen cap may be presented to a user.
    Type: Application
    Filed: March 17, 2021
    Publication date: July 8, 2021
    Inventors: John Sjolund, Ambika Srinath, Andrew Bochenko, George Crothall, Bryan Mazlish, Jennifer Martin Block, Sarah Matarese, Linda Mackowiak, Lane Desborough
  • Patent number: 11027073
    Abstract: A monitoring feature, such as, for example, a pen cap, for an insulin delivery device may include at least one circuit adapted to detect at least one of a capping or decapping of the pen cap from an insulin pen and a processor for using information to the at least one of a capping or decapping of the pen cap. A monitoring feature for an insulin delivery device includes at least one circuit adapted to detect use of the insulin delivery device.
    Type: Grant
    Filed: December 12, 2018
    Date of Patent: June 8, 2021
    Assignee: Bigfoot Biomedical, Inc.
    Inventors: John Sjolund, Ambika Srinath, Andrew Bochenko, George Crothall, Bryan Mazlish, Lane Desborough, Jennifer Martin Block, Sarah Matarese, Linda Mackowiak
  • Patent number: 10987464
    Abstract: One or more embodiments of the disclosure relate, generally, to a pen cap for a manual insulin delivery device. Such a pen cap may include a wireless communication interface, a detection circuit, a user interface, and a processor and memory. The detection circuit may be configured to detect cappings and decappings of the pen cap from a manual insulin delivery device. Timing information and recommendations related to capping and decapping of the pen cap may be presented to a user.
    Type: Grant
    Filed: December 12, 2018
    Date of Patent: April 27, 2021
    Assignee: Bigfoot Biomedical, Inc.
    Inventors: John Sjolund, Ambika Srinath, Andrew Bochenko, George Crothall, Bryan Mazlish, Jennifer Martin Block, Sarah Matarese, Linda Mackowiak, Lane Desborough
  • Publication number: 20190385752
    Abstract: A computer-implemented method for automated provisioning of clinical advice to a provider caring for a patient with diabetes (PWD). The method includes detecting a clinically relevant pattern in therapy data of a patient under the care of a provider, and identifying a predefined behavior of a PWD responsive to the detected clinically relevant pattern. The clinically relevant detected pattern is indicative of desirable behaviors and/or undesirable behaviors. The method further includes selecting a therapy insight associated with the identified predefined behavior, wherein the therapy insight comprises clinical advice associated with the PWD that includes a behavior recommendation, and responsive to the selecting the therapy insight, automatically sending, to a provider-dashboard associated with the provider caring for the PWD, the selected therapy insight.
    Type: Application
    Filed: June 14, 2019
    Publication date: December 19, 2019
    Inventors: Jacob Bowland, Bethany Leigh Salmon, Jennifer Martin Block, Alex Constantin, Sabine Kabel-Eckes, Jeff Boissier
  • Publication number: 20190381243
    Abstract: A method for presenting therapy insights that includes pre-generated content at an electronic device. The method comprising, at a device with one or more processors, memory and a display, displaying, on the display, and insulin therapy data. The therapy insight corresponding to a person with diabetes (PWD). The therapy insight generated based in part on the insulin therapy data of the PWD. The therapy insight includes pre-generated content. The pre-generated content includes clinical advice of insulin-based management of diabetes associated with the PWD.
    Type: Application
    Filed: June 14, 2019
    Publication date: December 19, 2019
    Inventors: Jacob Bowland, Bethany Leigh Salmon, Jennifer Martin Block, Alexandra Elena Constantin, Sabine Kabel-Eckes, Jeff Boissier
  • Publication number: 20190385728
    Abstract: A method for presenting insulin therapy setting recommendations associated with a therapy insight for a person with diabetes (PWD) at an electronic device. The method includes, at a device with one or more processors, memory, and a display, displaying on a dashboard of a PWD, at the display a first layer. The first layer includes a therapy insight corresponding to a PWD. The therapy insight generated based in part on insulin therapy data of the PWD. The therapy insight corresponds to insulin therapy of the PWD. The therapy insight comprises clinical advice for insulin-based management of PWDs diabetes. The first layer also includes an insulin therapy recommendation associated with the therapy insight. The insulin therapy recommendation corresponds to a pattern of behavior associated with the insulin-based management of the PWDs diabetes wherein the first layer overlays at least a portion of a second layer. The first layer overlays at least a portion of a second layer.
    Type: Application
    Filed: June 14, 2019
    Publication date: December 19, 2019
    Inventors: Jacob Bowland, Bethany Leigh Salmon, Jennifer Martin Block, Alexandra Elena Constantin, Sabine Kabel-Eckes, Jeff Boissier
  • Publication number: 20190385721
    Abstract: A method for receiving insulin therapy information related to insulin-based management of person with diabetes (PWD) at a provider-dashboard associated with a provider caring for the PWD. The method includes displaying, on the display, a therapy insight, at a provider-dashboard associated with a provider caring for a PWD. The therapy insight comprises clinical advice for insulin-based management of the person's diabetes. The method further includes receiving insulin therapy information related to insulin-based management of the person's diabetes provided at the provider-dashboard, and updating the therapy insight to include the insulin therapy information.
    Type: Application
    Filed: June 14, 2019
    Publication date: December 19, 2019
    Inventors: Jacob Bowland, Bethany Leigh Salmon, Jennifer Martin Block, Alexandra Elena Constantin, Sabine Kabel-Eckes, Jeff Boissier
  • Patent number: D911355
    Type: Grant
    Filed: March 29, 2018
    Date of Patent: February 23, 2021
    Assignee: Bigfoot Biomedical, Inc.
    Inventors: Sabine Kabel-Eckes, Jeff Boissier, Jennifer Martin Block, Bryan Mazlish